Futura Medical is developing a portfolio of innovative products for two large markets, sexual health and pain.
Desctiption: Topical gel for erectile dysfunction
Status: Phase 3 study completed. Regulatory submissions targeted for mid 2020. Out-licensing discussions ongoing.
Desctiption: Topical diclofenac pain relief gel
Status: Regulatory dossier submitted in the UK. UK licence partner addressing queries with support from Futura. Licensing discussions for further territories ongoing.